false
OasisLMS
Catalog
GLP1-s and Beyond: Weight Loss Medications in your ...
GLP1-s and Beyond Weight Loss Medications in Your ...
GLP1-s and Beyond Weight Loss Medications in Your Bariatric Endoscopy Practice
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The webinar discussed the complexities of obesity and the use of GLP-1 agonists for weight management and diabetes control. Dr. Narang and Dr. Phan highlighted the challenges of obesity treatment and the efficacy of medications like semaglutide and terzepatide. They emphasized the importance of lifestyle changes alongside medication for sustained weight loss. The webinar also covered the integration of GLP-1 therapy with bariatric endoscopy procedures like intragastric balloons and sleeve gastrectomy to address insufficient weight loss or weight regain post-procedure. Adverse events and effective management strategies were discussed, underlining the need for a comprehensive approach to treating obesity. In another presentation, Dr. Narang and Dr. Khan addressed counseling for GLP-1 agonist side effects, management strategies, and considerations for patients with specific conditions like IBD and poorly controlled diabetes. They also discussed the combination of GLP-1 agonists with bariatric endoscopy procedures for rapid weight loss and upcoming ESG devices. Individualized treatment plans based on patient needs were highlighted throughout both presentations.
Keywords
obesity
GLP-1 agonists
weight management
diabetes control
semaglutide
terzepatide
lifestyle changes
bariatric endoscopy procedures
intragastric balloons
sleeve gastrectomy
×
Please select your language
1
English